View source for PINK1

{{Short description|Protein-coding gene in the species Homo sapiens}}
{{cs1 config|name-list-style=vanc}}
{{Infobox_gene}}
'''[[PTEN (gene)|PTEN]]-induced kinase 1''' ('''PINK1''') is a mitochondrial [[Serine/threonine-specific protein kinase|serine/threonine-protein kinase]] encoded by the ''PINK1'' [[gene]].<ref name="pmid11494141">{{cite journal | vauthors = Unoki M, Nakamura Y | title = Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway | journal = Oncogene | volume = 20 | issue = 33 | pages = 4457–65 | date = Aug 2001 | pmid = 11494141 | doi = 10.1038/sj.onc.1204608 | doi-access = free }}</ref><ref name="pmid15349860">{{cite journal | vauthors = Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, Caputo V, Romito L, Albanese A, Dallapiccola B, Bentivoglio AR | title = PINK1 mutations are associated with sporadic early-onset parkinsonism | journal = Ann Neurol | volume = 56 | issue = 3 | pages = 336–41 | date = Sep 2004 | pmid = 15349860 | doi = 10.1002/ana.20256 | s2cid = 11049051 }}</ref>
It is thought to protect cells from stress-induced [[mitochondrion|mitochondrial]] dysfunction. PINK1 activity causes the [[Parkin (ligase)|parkin]] [[protein]] to bind to depolarized mitochondria to induce [[autophagy]] of those mitochondria.<ref>{{cite journal | vauthors = Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ | title = PINK1 is selectively stabilized on impaired mitochondria to activate Parkin | journal = [[PLOS Biology]] | volume = 8 | issue = 1 | pages = e1000298 | year = 2010 | pmid = 20126261 | pmc = 2811155 | doi = 10.1371/journal.pbio.1000298 | doi-access = free }}</ref><ref>{{cite journal | vauthors = Lazarou M, Narendra DP, Jin SM, Tekle E, Banerjee S, Youle RJ | title = PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding | journal = [[Journal of Cell Biology]] | volume = 200 | issue = 2 | pages = 163–172 | year = 2013 | pmid = 23319602 | doi = 10.1083/jcb.201210111 | pmc=3549971}}</ref>  PINK1 is processed by healthy mitochondria and released to trigger neuron differentiation.<ref>{{cite journal | vauthors = Dagda RK, Pien I, Wang R, Zhu J, Wang KZ, Callio J, Banerjee TD, Dagda RY, Chu CT | title = Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through protein kinase A | journal = [[J Neurochem]] | year = 2013 | pmid = 24151868 | doi = 10.1111/jnc.12494 | volume=128 | issue = 6 | pages=864–877 | pmc=3951661}}</ref> Mutations in this gene cause one form of autosomal recessive early-onset [[Parkinson's disease]].<ref name="entrez">{{cite web | title = Entrez Gene: PINK1 PTEN induced putative kinase 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=65018}}</ref>
== Structure ==
PINK1 is synthesized as a 63000 [[Atomic mass unit|Da]] protein which is often cleaved by [[PARL]], between the 103-Alanine and the 104-Phenylalanine residues, into a 53000 Da fragment.<ref>{{cite journal | vauthors = Deas E, Plun-Favreau H, Gandhi S, Desmond H, Kjaer S, Loh SH, Renton AE, Harvey RJ, Whitworth AJ, Martins LM, Abramov AY, Wood NW | title = PINK1 cleavage at position A103 by the mitochondrial protease PARL | journal = Hum. Mol. Genet. | volume = 20 | issue = 5 | pages = 867–869 | date = 2011 | pmid = 21138942 | pmc = 3033179 | doi = 10.1093/hmg/ddq526 }}</ref> PINK1 contains an [[N-terminal]] mitochondrial localization sequence, a putative transmembrane sequence, a Ser/Thr [[protein kinase domain|kinase domain]], and a [[C-terminal]] regulatory sequence. The protein has been found to localize to the outer membrane of mitochondria, but can also be found throughout the cytosol. Experiments suggest the Ser/Thr kinase domain faces outward toward the cytosol, indicating a possible point of interaction with parkin.<ref name="pmid21187721">{{cite journal | vauthors = Springer W, Kahle PJ | title = Regulation of PINK1-Parkin-mediated mitophagy | journal = Autophagy | volume = 7 | issue = 3 | pages = 266–78 |date=March 2011  | pmid = 21187721 | doi = 10.4161/auto.7.3.14348 | s2cid = 31612944 | doi-access =  }}</ref>
The structure of PINK1 has been solved and shows how the protein binds and phosphorylates its substrate ubiquitin.<ref>{{Cite journal|last1=Schubert|first1=Alexander F.|last2=Gladkova|first2=Christina|last3=Pardon|first3=Els|last4=Wagstaff|first4=Jane L.|last5=Freund|first5=Stefan M. V.|last6=Steyaert|first6=Jan|last7=Maslen|first7=Sarah L.|last8=Komander|first8=David|date=2017-10-30|title=Structure of PINK1 in complex with its substrate ubiquitin|journal=Nature|volume=552|issue=7683|pages=51–56|language=En|doi=10.1038/nature24645|pmid=29160309|pmc=6020998|issn=1476-4687|bibcode=2017Natur.552...51S}}</ref>
== Function ==
PINK1 is intimately involved with mitochondrial quality control by identifying damaged mitochondria and [[mitophagy|targeting specific mitochondria for degradation]]. Healthy mitochondria maintain a membrane potential that can be used to import PINK1 into the inner membrane where it is cleaved by PARL and cleared from the outer membrane. Severely damaged mitochondria lack sufficient membrane potential to import PINK1, which then accumulates on the outer membrane. PINK1 then recruits parkin to target the damaged mitochondria for degradation through [[autophagy]].<ref>{{cite journal | vauthors = Youle RJ, van der Bliek AM | title = Mitochondrial fission, fusion, and stress. | journal = Science | volume = 337 | issue = 6098 | pages = 1062–1065 | date = 2012 | pmid = 22936770 | doi = 10.1126/science.1219855 | pmc=4762028| bibcode = 2012Sci...337.1062Y }}</ref>  Due to the presence of PINK1 throughout the cytoplasm, it has been suggested that PINK1 functions as a "scout" to probe for damaged mitochondria.<ref>{{cite journal | vauthors = Narendra D, Walker JE, Youle R | title = Mitochondrail quality control mediated by PINK1 and Parkin: links to parkinsonism | journal =  Cold Spring Harbor Perspectives in Biology| volume = 4 | issue = 11 | pages = a011338 | date = 2012 | pmid = 23125018 | doi = 10.1101/cshperspect.a011338 | pmc=3536340}}</ref>
[[File:Degradation of damaged mitochondria with PINK1.png|thumbnail|left|Damaged mitochondria is being recognized by PINK1. PINK1 builds up on the outer membrane of the mitochondria and recruits parkin. The PINK1/parkin pathway then designates the mitochondria for degradation by lysosomes.]]
[[File:PINK1 with healthy mitochondria.png|thumbnail|left|Healthy mitochondria can import PINK1 where it is subsequently cleaved by [[PARL]]. This prevents any buildup of PINK1 and parkin is not recruited to the mitochondria.]]
PINK1 may also control mitochondria quality through [[mitochondrial fission]]. Through mitochondrial fission, a number of daughter mitochondria are created, often with an uneven distribution in membrane potential. Mitochondria with a strong, healthy membrane potential were more likely to undergo fusion than mitochondria with low membrane potential. Interference with the mitochondrial fission pathway led to an increase in oxidized proteins and a decrease in respiration.<ref>{{cite journal | vauthors = Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS | title = Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. | journal = The EMBO Journal | volume = 27 | issue = 2 | pages = 433–446 | date = 2008 | pmid = 18200046 | pmc = 2234339 | doi = 10.1038/sj.emboj.7601963 }}</ref> Without PINK1, parkin cannot efficiently localize to damaged mitochondria, while an over-expression of PINK1 causes parkin to localize to even healthy mitochondria.<ref>{{cite journal | vauthors = Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, May J, Tocilescu MA, Liu W, Ko HS, Magrané J, Moore DJ, Dawson VL, Grailhe R, Dawson TM, Li C, Tieu K, Przedborski S | title = PINK1-dependent recruitment of Parkin to mitochondria in mitophagy | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 107 | issue = 1 | pages = 378–83 | date = 2010 | pmid = 19966284 | doi = 10.1073/pnas.0911187107 | pmc=2806779| bibcode = 2010PNAS..107..378V | doi-access = free }}</ref>  Furthermore, mutations in both Drp1, a mitochondrial fission factor, and PINK1 were fatal in [[Drosophila]] models. However, an over-expression of Drp1 could rescue subjects deficient in PINK1 or parkin, suggesting mitochondrial fission initiated by Drp1 recreates the same effects of the PINK1/parkin pathway.<ref>{{cite journal | vauthors = Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ | title = The PINK1/Parkin pathway regulates mitochondrial mitophagy | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 105 | issue = 5 | pages = 1638–43 | date = 2008 | pmid = 18230723 | doi = 10.1073/pnas.0709336105 | pmc=2234197| doi-access = free }}</ref>
In addition to mitochondrial fission, PINK1 has been implicated in mitochondrial motility. The accumulation of PINK1 and recruitment of parkin targets a mitochondrion for degradation, and PINK1 may serve to enhance degradation rates by arresting mitochondrial motility. Over-expression of PINK1 produced similar effects to silencing [[Miro (protein)|Miro]], a protein closely associated with mitochondrial migration.<ref>{{cite journal | vauthors = Liu S, Sawada T, Lee S, Yu W, Silverio G, Alapatt P, Millan I, Shen A, Saxton W, Kanao T, Takahashi R, Hattori N, Imai Y, Lu B | title = Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. | journal = PLOS Genetics | volume = 8 | issue = 3 | pages = e102537 | date = 2012 | pmid = 22396657 | doi = 10.1371/journal.pgen.1002537 | pmc=3291531 | doi-access = free }}</ref>
Another mechanism of mitochondrial quality control may arise through mitochondria-derived vesicles. Oxidative stress in mitochondria can produce potentially harmful compounds including improperly folded proteins or reactive oxygen species. PINK1 has been shown to facilitate the creation of mitochondria-derived vesicles which can separate reactive oxygen species and shuttle them toward [[lysosomes]] for degradation.<ref>{{cite journal | vauthors = McLelland GL, Soubannier V, Chen CX, McBride HM, Fon EA | title = Parkin and PINK 1 function in a vesicular trafficking pathway regulating mitochondrial quality control | journal = The EMBO Journal | volume = 33 | issue = 4 | pages = 282–295 | date = 2014 | pmid = 24446486 | doi = 10.1002/embj.201385902 | pmc=3989637}}</ref>
== Disease relevance ==
Parkinson's disease is often characterized by the degeneration of [[dopaminergic neuron]]s and associated with the build-up of improperly folded proteins and [[Lewy bodies]]. Mutations in the PINK1 protein have been shown to lead to a build-up of such improperly folded proteins in the mitochondria of both fly and human cells.<ref>{{cite journal | vauthors = Pimenta de Castro I, Costa AC, Lam D, Tufi R, Fedele V, Moisoi N, Dinsdale D, Deas E, Loh SH, Martins LM | title = Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster. | journal = Cell Death & Differentiation | volume = 19 | issue = 8 | pages = 1308–16 | date = 2012 | pmid = 22301916 | doi = 10.1038/cdd.2012.5 | pmc=3392634}}</ref> Specifically, mutations in the serine/threonine kinase domain have been found in a number of Parkinson's patients where PINK1 fails to protect against stress-induced mitochondrial dysfunction and [[apoptosis]].<ref>{{cite journal | vauthors = Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, González-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW | title = Hereditary early-onset Parkinson's disease caused by mutations in PINK1. | journal = Science | volume = 304 | issue = 5674 | pages = 1158–60 | date = 2004 | pmid = 15087508 | doi = 10.1126/science.1096284 | bibcode = 2004Sci...304.1158V | s2cid = 33630092 | doi-access = free }}</ref>
{{Clear}}
== Pharmacological manipulation ==
To date, there have been few reports of small molecules that activate PINK1 and their promise as potential treatments for Parkinson's disease. The first report appeared in 2013 when Kevan Shokat and his team from UCSF identified a nucleobase called kinetin as an activator of PINK1.<ref>{{cite journal | vauthors = Hertz NT, Berthet A, Sos ML, Thorn KS, Burlingame AL, Nakamura K, Shokat KM | title = A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1 | journal = Cell | volume = 154 | issue = 4 | pages = 737–47 | year = 2013 | pmid = 23953109 |doi = 10.1016/j.cell.2013.07.030 | pmc=3950538}}</ref> Subsequently, it was shown by others that the nucleoside derivative of kinetin, i.e. kinetin riboside, exhibited significant activation of PINK1 in cells.<ref>{{cite journal | vauthors = Osgerby L, Lai YC, Thornton PJ, Amalfitano J, Le Duff CS, Jabeen I, Kadri H, Miccoli A, Tucker JH, Muqit M, Mehellou Y | title = Kinetin Riboside and Its ProTides Activate the Parkinson's Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization | journal = J. Med. Chem. | volume = 60 | issue = 8 | pages = 3518–24 | year = 2017 | pmid = 28323427 |doi = 10.1021/acs.jmedchem.6b01897 | pmc=5410652}}</ref> Additionally, the monophosphate prodrugs of kinetin riboside, ProTides, also showed activation of PINK1.<ref>{{cite journal | vauthors = Osgerby L, Lai YC, Thornton PJ, Amalfitano J, Le Duff CS, Jabeen I, Kadri H, Miccoli A, Tucker JH, Muqit M, Mehellou Y | title = Kinetin Riboside and Its ProTides Activate the Parkinson's Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization | journal = J. Med. Chem. | volume = 60 | issue = 8 | pages = 3518–24 | year = 2017 | pmid = 28323427 |doi = 10.1021/acs.jmedchem.6b01897 | pmc=5410652}}</ref> In December 2017, niclosamide, an anthelmintic drug, was identified as a potent activator of PINK1 in cells and in neurons.<ref>{{cite journal | vauthors = Barini E, Miccoli A, Tinarelli F, Mulholand K, Kadri H, Khanim F, Stojanovski L, Read KD, Burness K, Blow JJ, Mehellou Y, Muqit M | title = The Anthelmintic Drug Niclosamide and its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1 | journal = ChemBioChem | volume = 19 | issue = 5 | pages = 425–429 | year = 2017 | pmid = 29226533 | pmc = 5901409 |doi = 10.1002/cbic.201700500 }}</ref>
== References ==
{{Reflist|35em}}
== Further reading ==
{{Refbegin|35em}}
* {{cite book | vauthors = Heutink P | title = Parkinson's Disease and Related Disorders | chapter = PINK-1 and DJ-1 — new genes for autosomal recessive Parkinson's disease | journal = J. Neural Transm. Suppl. | volume = 70 | issue = 70 | pages = 215–9 | year = 2006 | pmid = 17017532 | doi = 10.1007/978-3-211-45295-0_33 | isbn = 978-3-211-28927-3 | series = Journal of Neural Transmission. Supplementa }}
* {{cite journal | vauthors = Valente EM, Bentivoglio AR, Dixon PH, Ferraris A, Ialongo T, Frontali M, Albanese A, Wood NW | title = Localization of a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, PARK6, on Human Chromosome 1p35-p36 | journal = Am. J. Hum. Genet. | volume = 68 | issue = 4 | pages = 895–900 | year = 2001 | pmid = 11254447 | pmc = 1275643 | doi = 10.1086/319522 }}
* {{cite journal | vauthors = Khan NL, Valente EM, Bentivoglio AR, Wood NW, Albanese A, Brooks DJ, Piccini P | title = Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study | journal = Ann. Neurol. | volume = 52 | issue = 6 | pages = 849–53 | year = 2002 | pmid = 12447943 | doi = 10.1002/ana.10417 | s2cid = 9275470 }}
* {{cite journal | vauthors = Bonifati V, Dekker MC, Vanacore N, Fabbrini G, Squitieri F, Marconi R, Antonini A, Brustenghi P, Dalla Libera A, De Mari M, Stocchi F, Montagna P, Gallai V, Rizzu P, van Swieten JC, Oostra B, van Duijn CM, Meco G, Heutink P | title = Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7 | journal = Neurol. Sci. | volume = 23 | pages = S59–60 | year = 2003 | issue = Suppl 2 | pmid = 12548343 | doi = 10.1007/s100720200069 | s2cid = 13625056 }}
* {{cite journal | vauthors = Valente EM, Brancati F, Caputo V, Graham EA, Davis MB, Ferraris A, Breteler MM, Gasser T, Bonifati V, Bentivoglio AR, De Michele G, Dürr A, Cortelli P, Filla A, Meco G, Oostra BA, Brice A, Albanese A, Dallapiccola B, Wood NW | title = PARK6 is a common cause of familial parkinsonism | journal = Neurol. Sci. | volume = 23 | pages = S117–8 | year = 2003 | issue = Suppl 2 | pmid = 12548371 | doi = 10.1007/s100720200097 | s2cid = 21061495 }}
* {{cite journal | vauthors = Nakajima A, Kataoka K, Hong M, Sakaguchi M, Huh NH | title = BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential | journal = Cancer Lett. | volume = 201 | issue = 2 | pages = 195–201 | year = 2004 | pmid = 14607334 | doi = 10.1016/S0304-3835(03)00443-9 }}
* {{cite journal | vauthors = Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, González-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW | title = Hereditary early-onset Parkinson's disease caused by mutations in PINK1 | journal = Science | volume = 304 | issue = 5674 | pages = 1158–60 | year = 2004 | pmid = 15087508 | doi = 10.1126/science.1096284 | bibcode = 2004Sci...304.1158V | s2cid = 33630092 | doi-access = free }}
* {{cite journal | vauthors = Healy DG, Abou-Sleiman PM, Ahmadi KR, Muqit MM, Bhatia KP, Quinn NP, Lees AJ, Latchmann DS, Goldstein DB, Wood NW | title = The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism | journal = Ann. Neurol. | volume = 56 | issue = 3 | pages = 329–35 | year = 2004 | pmid = 15349859 | doi = 10.1002/ana.20206 | s2cid = 1235813 }}
* {{cite journal | vauthors = Hatano Y, Li Y, Sato K, Asakawa S, Yamamura Y, Tomiyama H, Yoshino H, Asahina M, Kobayashi S, Hassin-Baer S, Lu CS, Ng AR, Rosales RL, Shimizu N, Toda T, Mizuno Y, Hattori N | title = Novel PINK1 mutations in early-onset parkinsonism | journal = Ann. Neurol. | volume = 56 | issue = 3 | pages = 424–7 | year = 2004 | pmid = 15349870 | doi = 10.1002/ana.20251 | s2cid = 10853835 }}
* {{cite journal | vauthors = Hatano Y, Sato K, Elibol B, Yoshino H, Yamamura Y, Bonifati V, Shinotoh H, Asahina M, Kobayashi S, Ng AR, Rosales RL, Hassin-Baer S, Shinar Y, Lu CS, Chang HC, Wu-Chou YH, Ataç FB, Kobayashi T, Toda T, Mizuno Y, Hattori N | title = PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations | journal =   Neurology| volume =  63| issue =  8| pages = 1482–5| year =  2004| pmid = 15505170 | doi = 10.1212/01.wnl.0000142258.29304.fe | s2cid = 13480500 }}
* {{cite journal | vauthors = Healy DG, Abou-Sleiman PM, Gibson JM, Ross OA, Jain S, Gandhi S, Gosal D, Muqit MM, Wood NW, Lynch T | title = PINK1 (PARK6) associated Parkinson disease in Ireland | journal = Neurology | volume = 63 | issue = 8 | pages = 1486–8 | year = 2006 | pmid = 15505171 | doi = 10.1212/01.wnl.0000142089.38301.8e | s2cid = 24418905 }}
* {{cite journal | vauthors = Rogaeva E, Johnson J, Lang AE, Gulick C, Gwinn-Hardy K, Kawarai T, Sato C, Morgan A, Werner J, Nussbaum R, Petit A, Okun MS, McInerney A, Mandel R, Groen JL, Fernandez HH, Postuma R, Foote KD, Salehi-Rad S, Liang Y, Reimsnider S, Tandon A, Hardy J, St George-Hyslop P, Singleton AB | title = Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease | journal =  Archives of Neurology| volume = 61 | issue = 12 | pages = 1898–904 | year = 2005 | pmid = 15596610 | doi = 10.1001/archneur.61.12.1898 | doi-access =  }}
* {{cite journal | vauthors = Beilina A, Van Der Brug M, Ahmad R, Kesavapany S, Miller DW, Petsko GA, Cookson MR | title = Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 102 | issue = 16 | pages = 5703–8 | year = 2005 | pmid = 15824318 | pmc = 556294 | doi = 10.1073/pnas.0500617102 | bibcode = 2005PNAS..102.5703B | doi-access = free }}
* {{cite journal | vauthors = Deng H, Le WD, Zhang X, Pan TH, Jankovic J | title = G309D and W437OPA PINK1 mutations in Caucasian Parkinson's disease patients | journal = Acta Neurol. Scand. | volume = 111 | issue = 6 | pages = 351–2 | year = 2005 | pmid = 15876334 | doi = 10.1111/j.1600-0404.2005.00383.x | s2cid = 10669009 | doi-access = free }}
* {{cite journal | vauthors = Li Y, Tomiyama H, Sato K, Hatano Y, Yoshino H, Atsumi M, Kitaguchi M, Sasaki S, Kawaguchi S, Miyajima H, Toda T, Mizuno Y, Hattori N | title = Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism | journal = Neurology | volume = 64 | issue = 11 | pages = 1955–7 | year = 2005 | pmid = 15955953 | doi = 10.1212/01.WNL.0000164009.36740.4E | s2cid = 46024206 }}
{{Refend}}
== External links ==
* [https://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=pink1-pd  GeneReviews/NCBI/NIH/UW entry on PINK1 Type of Young-Onset Parkinson Disease]